<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04023474</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201901618</org_study_id>
    <nct_id>NCT04023474</nct_id>
  </id_info>
  <brief_title>Platelet-Rich Fibrin in the Healing of Regional and Free Flaps</brief_title>
  <official_title>Role of Platelet-Rich Fibrin in the Healing of Regional and Free Flap Donor Sites for Head and Neck Surgery Patients: A Prospective Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Determine if the use of platelet-rich fibrin (PRF) versus historical treatment methods
      improves the post-operative management of healing complications from flap donor sites.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 16, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in healing time at 3 months post-operative</measure>
    <time_frame>Up to 3 months</time_frame>
    <description>Improved healing of PRF patients compared to control group.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">65</enrollment>
  <condition>Head and Neck Disorder</condition>
  <condition>Free Flap</condition>
  <arm_group>
    <arm_group_label>Platelet Rich Fibrin (PRF) Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to this group will receive treatment with a PRF graft in clinic at the time any pertinent post-operative complication is identified.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Platelet Rich Fibrin Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in the observational control group will be managed at the time of the complication by standard of care methods.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Platelet Rich Fibrin (PRF) Application</intervention_name>
    <description>Platelet Rich Fibrin application to flap defect.</description>
    <arm_group_label>Platelet Rich Fibrin (PRF) Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who had surgery involving a microvascular free flap or a myocutaneous
             regional flap for head and neck reconstruction who develop one of the following donor
             site complications: wound dehiscence, wound margin breakdown or contraction resulting
             in healing by secondary intention, myocutaneous fistula formation, or incomplete
             coverage of the donor site by a skin graft placed in the operating room.

        Exclusion Criteria:

          -  Patients under 18 years of age

          -  Patient's unable to participate in blood draw either due to medical compromise,
             inability to tolerate the procedure, or inability of the physician to successfully
             draw the blood at the time of appointment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Salam Salman, MD, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Salam Salman, MD, DDS</last_name>
    <phone>904-244-3901</phone>
    <email>salam.salman@jax.ufl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stacy Smith</last_name>
    <phone>904-244-3884</phone>
    <email>stacy.smith@jax.ufl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UF Health Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>July 12, 2019</study_first_submitted>
  <study_first_submitted_qc>July 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2019</study_first_posted>
  <last_update_submitted>January 2, 2020</last_update_submitted>
  <last_update_submitted_qc>January 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Platelet-Rich Fibrin (PRF)</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>IPD will not be shared with other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

